Name: Biosensor Technologies for Prostate Cancer: Early Detection and Precision Diagnosis (en Inglés)
SKU: 66955075
Price: 135.37 USD
Availability: InStock
Author: Srivastava, Shriyansh; Ravindra Babu, Molakpogu; Shekhar, Shashank

portada Biosensor Technologies for Prostate Cancer: Early Detection and Precision Diagnosis (en Inglés)

Biosensor Technologies for Prostate Cancer: Early Detection and Precision Diagnosis (en Inglés)

Formato

Libro Físico

Editorial

Springer

Autor

Srivastava, Shriyansh; Ravindra Babu, Molakpogu; Shekhar, Shashank

Idioma

Inglés

N° páginas

340

Encuadernación

Tapa Dura

ISBN13

9789819586431

Biosensor Technologies for Prostate Cancer: Early Detection and Precision Diagnosis (en Inglés)

Srivastava, Shriyansh; Ravindra Babu, Molakpogu; Shekhar, Shashank (Autor) · Springer · Tapa Dura

Libro Nuevo Importado

Envío: 20 a 27 días háb.

$ 270.74$ 135.37

-50%

Costos de importación incluídos en el precio ✅

Libro Nuevo

Quedan más de 100 unidades

$ 135.37

Llega entre el 21 Sep y el 02 Oct a Quito, Pichincha. Seleccionar ubicación

Agregar a lista de deseos

Reseña del libro "Biosensor Technologies for Prostate Cancer: Early Detection and Precision Diagnosis (en Inglés)"

The book covers the latest scientific advances in biomarker identification, sensor design, and point-of-care diagnostic systems tailored for early-stage prostate cancer. It explains how biosensors function, their role in overcoming limitations of traditional diagnostic tools, and their impact on personalized medicine. The book focuses on integrating interdisciplinary knowledge, combining insights from biotechnology, nanotechnology, and clinical oncology. It includes chapters that explain different types of biosensors, electrochemical, optical, and nanomaterial-based, while discussing their real-world applications and clinical relevance. A special chapter is dedicated to prostate cancer-specific biomarkers and sensor platforms, providing readers with a focused understanding of disease-targeted diagnostics. This book benefits researchers, clinicians, biomedical engineers, and graduate students by offering practical insights and future directions in diagnostic innovation. It serves as a valuable resource for anyone aiming to improve early detection and management of prostate cancer, making it essential for academic, research, and clinical settings.